Cover image for Vol. 10 Issue 8

Editor-in-Chief: Natalia Ortúzar

Impact Factor: 2.968

ISI Journal Citation Reports © Ranking: 2014: 19/59 (Chemistry Medicinal); 83/254 (Pharmacology & Pharmacy)

Online ISSN: 1860-7187

Associated Title(s): Angewandte Chemie International Edition, Chemistry - A European Journal, Chemistry – An Asian Journal, ChemBioChem, Medicinal Research Reviews, Molecular Informatics

Recently Published Issues

See all

Latest News

Browse more news


Follow ChemMedChem on Twitter

July 30, 2015

Gutenberg Research Award Goes to Kataoka

Gutenberg Research Award Goes to KataokaIn recognition of his outstanding research accomplishments, ChemMedChem International Advisory Board member Kazunori Kataoka (University of Tokyo) has been awarded the 2015 Gutenberg Research Award by the Gutenberg Research School at the University of Mainz. Read more...

Your Comment...

[Browse more news]

Recently Published Articles

  1. Polarization Transfer from Ligands Hyperpolarized by Dissolution Dynamic Nuclear Polarization for Screening in Drug Discovery

    Hlaing Min, Dr. Giridhar Sekar and Prof. Christian Hilty

    Article first published online: 4 AUG 2015 | DOI: 10.1002/cmdc.201500241

    Thumbnail image of graphical abstract

    Fingerprints at the scene: A hyperpolarized ligand binds to a protein and selectively enhances its NMR signal. The resulting “fingerprint” enables rapid and unambiguous detection of the interaction in an experiment that can serve as an alternative to saturation transfer difference for drug discovery.

  2. Exploring the Effects of Glycosylation and Etherification of the Side Chains of the Anticancer Drug Mitoxantrone

    Pazit Shaul, Kfir B. Steinbuch, Eran Blacher, Prof. Reuven Stein and Dr. Micha Fridman

    Article first published online: 31 JUL 2015 | DOI: 10.1002/cmdc.201500274

    Thumbnail image of graphical abstract

    Sweets on the side: Derivatization of the antitumor drug mitoxantrone trough symmetric and asymmetric O-glycosylation or methyl etherification of the drugs’ side chains can improve DNA affinity, affects both in vitro and in vivo activity, and can inhibit the formation of potentially toxic metabolites.

  3. Application of MS Transport Assays to the Four Human γ-Aminobutyric Acid Transporters

    Dr. Sebastian Schmitt, Dr. Georg Höfner and Prof. Dr. Klaus T. Wanner

    Article first published online: 27 JUL 2015 | DOI: 10.1002/cmdc.201500254

    Thumbnail image of graphical abstract

    MS Transport Assays: We describe the application of mass spectrometry based MS Transport Assays toward all four human γ-aminobutyric acid (GABA) transporters. Data for several inhibitors are presented and compared with state-of-the-art radiometric uptake assays. Moreover, a method to evaluate the inhibition curves by taking nonspecific transport into account is discussed in detail.

  4. Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design

    Pankaj Mishra, Dr. Senthil R. Ayyannan and Dr. Gautam Panda

    Article first published online: 24 JUL 2015 | DOI: 10.1002/cmdc.201500215

    Thumbnail image of graphical abstract

    New horizons in biospace: Although the utility of structure-based drug design principles in devising ways to inhibit β-amyloid aggregation with small molecules is still in its early stages, there are unexplored avenues that can be taken in this regard. Herein we discuss the current state of the art in this field of developing drugs to combat Alzheimer′s disease.

  5. Synthesis and Antiplasmodial Activity of Novel Chloroquine Analogues with Bulky Basic Side Chains

    Dr. Bruno Tasso, Dr. Federica Novelli, Dr. Michele Tonelli, Dr. Anna Barteselli, Dr. Nicoletta Basilico, Dr. Silvia Parapini, Prof. Donatella Taramelli, Prof. Anna Sparatore and Prof. Fabio Sparatore

    Article first published online: 24 JUL 2015 | DOI: 10.1002/cmdc.201500195

    Thumbnail image of graphical abstract

    Where the action is: We synthesized a new series of chloroquine (CQ) analogues characterized by a side chain terminated with a bulky basic head group. Most compounds were found to be active against the D-10 (CQ-susceptible) and W-2 (CQ-resistant) strains of Plasmodium falciparum, with nanomolar and sub-micromolar IC50 values. Four derivatives appear to be of particular interest in terms of their high potency and low cytotoxicity.